Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Avineuro Pharmaceuticals Inc.
DescriptionSmall molecule serotonin (5-HT6) receptor antagonist
Molecular Target Serotonin (5-HT6) receptor
Mechanism of ActionSerotonin (5-HT6) receptor antagonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationSchizophrenia
Indication DetailsTreat schizophrenia
Regulatory Designation
PartnerAllaChem LLC

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today